CervoMed CRVO
NASDAQ CRVO
$2.95 +0.02 (+0.85%)
As of: Oct 2, 2026 · 11:59 AM EDT

CervoMed (CRVO) Gross Profit (2011 - 2013)

Updated

CervoMed (CRVO) reported Gross Profit of $71,667 for Q2 2013, down 49.7% from $142,484 a year earlier.

Analysis

CervoMed (CRVO) Gross Profit (2011 - 2013) Analysis & Trends

For FY2012, CervoMed posted Gross Profit of $138,739.

  • By year, Gross Profit came in at -$1.74 million in FY2011 and -$170,204 in FY2010.
  • The Q2 2013 figure ranks as the lowest quarterly Gross Profit since Q1 2012.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 CervoMed 30.43 Mn 30.43 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2013 71,667.00
Sep 30, 2012 142,484.00
Jun 30, 2012 142,484.00
Mar 31, 2012 -68,960.00
Dec 31, 2011 -1.73 Mn
Sep 30, 2011 -3,609.00
API Access

CervoMed Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=CRVO&period=max&api_key=YOUR_API_KEY